Therapeutic agent for malignant mesothelioma

Details for Australian Patent Application No. 2007277703 (hide)

Owner Japan Science and Technology Agency

Inventors Yamamura, Hisako; Takahashi, Katsuhito

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007277703

PCT Pub. Number WO2008/013276

Priority 2006-205006 27.07.06 JP

Filing date 27 July 2007

Wipo publication date 31 January 2008

Acceptance publication date 6 September 2012

International Classifications

C12N 7/00 Viruses, e.g. bacteriophages

A61K 35/12 Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 35/76 Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 35/00 Antineoplastic agents

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12R 1/93

Event Publications

19 February 2009 PCT application entered the National Phase

  PCT publication WO2008/013276 Priority application(s): WO2008/013276

6 September 2012 Application Accepted

  Published as AU-B-2007277703

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007277704-Fused ring spiroketal derivative and use thereof as drug for treating diabetes

2007277684-Monoclonal antibody to soluble LOX-1